Phase II Trial of STI571 [imatinib mesylate] in Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2007
At a glance
- Drugs Imatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Aug 2007 Status changed from in progress to completed.
- 16 Sep 2005 New trial record.